| Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis JW Locasale, AR Grassian, T Melman, CA Lyssiotis, KR Mattaini, AJ Bass, ... Nature genetics 43 (9), 869-874, 2011 | 1226 | 2011 |
| Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma D Liu, B Schilling, D Liu, A Sucker, E Livingstone, L Jerby-Arnon, ... Nature medicine 25 (12), 1916-1927, 2019 | 778 | 2019 |
| Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities CM Gay, CA Stewart, EM Park, L Diao, SM Groves, S Heeke, BY Nabet, ... Cancer cell 39 (3), 346-360. e7, 2021 | 715 | 2021 |
| Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells CA Lewis, SJ Parker, BP Fiske, D McCloskey, DY Gui, CR Green, ... Molecular cell 55 (2), 253-263, 2014 | 630 | 2014 |
| Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors D Miao, CA Margolis, NI Vokes, D Liu, A Taylor-Weiner, SM Wankowicz, ... Nature genetics 50 (9), 1271-1281, 2018 | 546 | 2018 |
| Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma K Bi, MX He, Z Bakouny, A Kanodia, S Napolitano, J Wu, G Grimaldi, ... Cancer cell 39 (5), 649-661. e5, 2021 | 424 | 2021 |
| Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells SM Fendt, EL Bell, MA Keibler, BA Olenchock, JR Mayers, TM Wasylenko, ... Nature communications 4 (1), 2236, 2013 | 402 | 2013 |
| Metabolic pathway alterations that support cell proliferation MG Vander Heiden, SY Lunt, TL Dayton, BP Fiske, WJ Israelsen, ... Cold Spring Harbor symposia on quantitative biology 76, 325-334, 2011 | 344 | 2011 |
| Diminished efficacy of programmed death-(ligand) 1 inhibition in STK11-and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status B Ricciuti, KC Arbour, JJ Lin, A Vajdi, N Vokes, L Hong, J Zhang, ... Journal of Thoracic Oncology 17 (3), 399-410, 2022 | 273 | 2022 |
| Association of high tumor mutation burden in non–small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 … B Ricciuti, X Wang, JV Alessi, H Rizvi, NR Mahadevan, YY Li, A Polio, ... JAMA oncology 8 (8), 1160-1168, 2022 | 231 | 2022 |
| Transcriptional mediators of treatment resistance in lethal prostate cancer MX He, MS Cuoco, J Crowdis, A Bosma-Moody, Z Zhang, K Bi, A Kanodia, ... Nature medicine 27 (3), 426-433, 2021 | 147 | 2021 |
| Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao, Y Hou, A Flaifel, S Tang, ... Nature communications 12 (1), 808, 2021 | 122 | 2021 |
| Harmonization of tumor mutational burden quantification and association with response to immune checkpoint blockade in non–small-cell lung cancer NI Vokes, D Liu, B Ricciuti, E Jimenez-Aguilar, H Rizvi, F Dietlein, MX He, ... JCO precision oncology 3, 1-12, 2019 | 112 | 2019 |
| Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer A Ravi, MD Hellmann, MB Arniella, M Holton, SS Freeman, V Naranbhai, ... Nature genetics 55 (5), 807-819, 2023 | 87 | 2023 |
| Concurrent TP53 mutations facilitate resistance evolution in EGFR-mutant lung adenocarcinoma NI Vokes, E Chambers, T Nguyen, A Coolidge, CA Lydon, X Le, L Sholl, ... Journal of Thoracic Oncology 17 (6), 779-792, 2022 | 84 | 2022 |
| Integrative clinical and molecular characterization of translocation renal cell carcinoma Z Bakouny, A Sadagopan, P Ravi, NY Metaferia, J Li, S AbuHammad, ... Cell reports 38 (1), 2022 | 82 | 2022 |
| Machine learning models for the identification of prognostic and predictive cancer biomarkers: a systematic review Q Al-Tashi, MB Saad, A Muneer, R Qureshi, S Mirjalili, A Sheshadri, X Le, ... International journal of molecular sciences 24 (9), 7781, 2023 | 69 | 2023 |
| Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors S Abou Alaiwi, AH Nassar, W Xie, Z Bakouny, JE Berchuck, DA Braun, ... Cancer immunology research 8 (8), 1075-1084, 2020 | 68 | 2020 |
| MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma Y Qian, A Galan-Cobo, I Guijarro, M Dang, D Molkentine, A Poteete, ... Cancer Cell 41 (7), 1363-1380. e7, 2023 | 55 | 2023 |
| Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study MB Saad, L Hong, M Aminu, NI Vokes, P Chen, M Salehjahromi, K Qin, ... The Lancet Digital Health 5 (7), e404-e420, 2023 | 48 | 2023 |
